Insider · CIK 0001491140

O'Toole David D

Reports to the SEC for 6 companies · VALENCIA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001491140

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	RCELAVITA Medical, Inc.A Award	CFO	AAward	+2,000 sh	$3.97	+$7,940	152,927
2026-06-12	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+2,000 sh	$3.97	+$7,940	152,927
2026-05-29	RCELAVITA Medical, Inc.A Award	CFO	AAward	+5,000 sh	$3.05	+$15.3K	150,927
2026-05-20	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+2,000 sh	$4.26	+$8,520	145,927
2026-05-19	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+2,000 sh	$4.24	+$8,480	143,927
2026-03-11	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,800 sh	$4.78	+$8,604	141,927
2026-02-19	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+3,000 sh	$4.15	+$12.5K	140,127
2026-02-18	RCELAVITA Medical, Inc.A Award	CFO	AAward	+105K sh	—	—	137,127
2026-02-18	RCELAVITA Medical, Inc. · Stock Options (Right to Buy)A Award	CFO	AAward	+156K sh	—	—	155,510
2025-08-26	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+2,000 sh	$4.52	+$9,040	31,657
2025-08-12	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+2,000 sh	$4.81	+$9,620	29,657
2025-05-30	RCELAVITA Medical, Inc.A Award	CFO	AAward	+1,923 sh	$4.78	+$9,186.171	27,657
2025-02-20	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$9.90	+$9,900	25,734
2025-02-19	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$10.25	+$10.3K	24,734
2025-01-21	RCELAVITA Medical, Inc. · Stock Options (Right to Buy)A Award	CFO	AAward	+150K sh	—	—	150,000
2024-12-05	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+475 sh	$12.53	+$5,951.75	23,234
2024-12-05	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+500 sh	$12.40	+$6,200	23,734
2024-11-29	RCELAVITA Medical, Inc.A Award	CFO	AAward	+785 sh	$7.83	+$6,146.55	22,759
2024-05-31	RCELAVITA Medical, Inc.A Award	CFO	AAward	+2,240 sh	$8.17	+$18.3K	21,974
2024-05-30	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+500 sh	$9.20	+$4,600	19,234
2024-05-30	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+500 sh	$8.60	+$4,300	19,734
2024-02-28	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.38	+$17.4K	18,484
2024-02-28	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+250 sh	$17.43	+$4,357.5	18,734
2024-01-03	RCELAVITA Medical, Inc. · Stock Options (Right to Buy)A Award	CFO	AAward	+125K sh	—	—	125,000
2023-12-12	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+950 sh	$12.45	+$11.8K	17,484
2023-12-01	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+500 sh	$10.68	+$5,340	16,534
2023-11-30	RCELAVITA Medical, Inc.A Award	CFO	AAward	+1,034 sh	$9.06	+$9,369.074	16,034
2023-11-21	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$10.30	+$10.3K	14,000
2023-11-21	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$10.26	+$10.3K	15,000
2023-11-16	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$12.15	+$12.2K	12,000
2023-11-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$13.25	+$13.3K	11,000
2023-11-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$12.45	+$12.5K	13,000
2023-11-14	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$12.88	+$12.9K	10,000
2023-08-16	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.05	+$17.1K	8,000
2023-08-16	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.06	+$17.1K	9,000
2023-08-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.92	+$17.9K	3,000
2023-08-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.89	+$17.9K	4,000
2023-08-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.96	+$18K	5,000
2023-08-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.94	+$17.9K	6,000
2023-08-15	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$17.93	+$17.9K	7,000
2023-06-20	RCELAVITA Medical, Inc.P Purchase	CFO	PPurchase	+1,000 sh	$16.15	+$16.1K	2,000
2023-06-15	RCELAVITA Medical, Inc. · Stock Options (Right to Buy)A Award	CFO	AAward	+150K sh	—	—	150,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−22.5K sh	$20.00	−$450K	11,736
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−11.7K sh	$20.00	−$235K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+2,000 sh	—	—	2,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−33K sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−8,250 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10.8K sh	—	—	0
2023-01-27	OPIANT PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−541 sh	$20.26	−$11K	34,248

Recent filings

Accepted (ET)
Aug 244/A
O'Toole David D0001193125-26-363747
SEC(opens sec.gov)
Jun 124
O'Toole David D0001193125-26-269544
SEC(opens sec.gov)
Jun 14
O'Toole David D0001193125-26-251588
SEC(opens sec.gov)
May 204
O'Toole David D0001193125-26-232686
SEC(opens sec.gov)
May 194
O'Toole David D0001193125-26-230874
SEC(opens sec.gov)
Mar 114
O'Toole David D0001193125-26-102263
SEC(opens sec.gov)
Feb 234
O'Toole David D0001193125-26-064111
SEC(opens sec.gov)
Feb 194
O'Toole David D0001193125-26-059552
SEC(opens sec.gov)
Aug 264
O'Toole David D0000950170-25-111467
SEC(opens sec.gov)
Aug 124
O'Toole David D0000950170-25-107387
SEC(opens sec.gov)
Jun 24
O'Toole David D0000950170-25-080304
SEC(opens sec.gov)
Feb 204
O'Toole David D0000950170-25-024204
SEC(opens sec.gov)
Feb 194
O'Toole David D0000950170-25-023233
SEC(opens sec.gov)
Jan 224
O'Toole David D0000950170-25-007794
SEC(opens sec.gov)
Dec 54
O'Toole David D0000950170-24-133748
SEC(opens sec.gov)
Jun 34
O'Toole David D0000950170-24-068006
SEC(opens sec.gov)

Companies

Address

28159 AVENUE STANFORD SUITE 220 - AVITA MEDICAL

VALENCIA, CA, 91355